News
Suresh Ramalingam, MD | Winship Cancer Institutewinshipcancer.emory.edu › ramalingam-treatment-egfr-lung-cancer
winshipcancer.emory.edu
Suresh Ramalingam, MD Physician Scientist. "The results of our study usher in a new treatment paradigm for the treatment of patients with an EGFR-mutated ...
Suresh Ramalingam | Emory University | Atlanta, GA
www.news.emory.edu
Nationally recognized for his research, Winship Cancer Institute's Dr. Suresh Ramalingam has developed individualized therapies for patients with small cell and …
Press | NSCLC, cancer, osimertinib, Flaura ESMOwww.esmo.org › newsroom › press-office › esmo-congress-nsclc-can...
www.esmo.org
... for EGFR mutated patients,” said study author Prof Suresh Ramalingam, Winship Cancer Institute of Emory University, Atlanta, US. “This is ...
Winship Cancer Institute appoints deputy director
www.healio.com
Suresh S. Ramalingam, MD, has been named deputy director of Winship Cancer Institute of Emory University.In this role, he will oversee the integration of...
sorted by relevance / date